{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T18:04:07Z","timestamp":1776449047611,"version":"3.51.2"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T00:00:00Z","timestamp":1667779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PTDC\/EQU-EQU\/0142\/2020 PD\/BD\/135502\/2018 SFRH\/BD\/138937\/2018 UIDB\/04462\/2020 UIDP\/04462\/2020 LA\/P\/0087\/2020"],"award-info":[{"award-number":["PTDC\/EQU-EQU\/0142\/2020 PD\/BD\/135502\/2018 SFRH\/BD\/138937\/2018 UIDB\/04462\/2020 UIDP\/04462\/2020 LA\/P\/0087\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Bioeng. Biotechnol."],"abstract":"<jats:p>Adeno-associated viruses (AAVs) demand for clinical trials and approved therapeutic applications is increasing due to this vector\u2019s overall success and potential. The high doses associated with administration strategies challenges bioprocess engineers to develop more efficient technologies and innovative strategies capable of increasing volumetric productivity. In this study, alternating tangential flow (ATF) and Tangential Flow Depth filtration (TFDF) techniques were compared as to their potential for 1) implementing a high-cell-density perfusion process to produce AAV8 using mammalian HEK293 cells and transient transfection, and 2) integrating AAV harvest and clarification units into a single step. On the first topic, the results obtained demonstrate that AAV expression improves with a medium exchange strategy. This was evidenced firstly in the small-scale perfusion-mocking study and later verified in the 2\u00a0L bioreactor operated in perfusion mode. Fine-tuning the shear rate in ATF and TFDF proved instrumental in maintaining high cell viabilities and, most importantly, enhancing AAV-specific titers (7.6 \u00d7 10<jats:sup>4<\/jats:sup>\u00a0VG\/cell), i.e., up to 4-fold compared to non-optimized perfusion cultures and 2-fold compared with batch operation mode. Regarding the second objective, TFDF enabled the highest recovery yields during perfusion-based continuous harvest of extracellular virus and lysate clarification. This study demonstrates that ATF and TFDF techniques have the potential to support the production and continuous harvest of AAV, and enable an integrated clarification procedure, contributing to the simplification of operations and improving manufacturing efficiency.<\/jats:p>","DOI":"10.3389\/fbioe.2022.1020174","type":"journal-article","created":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T05:06:05Z","timestamp":1667797565000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":41,"title":["AAV process intensification by perfusion bioreaction and integrated clarification"],"prefix":"10.3389","volume":"10","author":[{"given":"Jo\u00e3o P.","family":"Mendes","sequence":"first","affiliation":[]},{"given":"B\u00e1rbara","family":"Fernandes","sequence":"additional","affiliation":[]},{"given":"Earl","family":"Pineda","sequence":"additional","affiliation":[]},{"given":"Shashi","family":"Kudugunti","sequence":"additional","affiliation":[]},{"given":"Mike","family":"Bransby","sequence":"additional","affiliation":[]},{"given":"Ren\u00e9","family":"Gantier","sequence":"additional","affiliation":[]},{"given":"Cristina","family":"Peixoto","sequence":"additional","affiliation":[]},{"given":"Paula M.","family":"Alves","sequence":"additional","affiliation":[]},{"given":"Ant\u00f3nio","family":"Rold\u00e3o","sequence":"additional","affiliation":[]},{"given":"Ricardo J. S.","family":"Silva","sequence":"additional","affiliation":[]}],"member":"1965","published-online":{"date-parts":[[2022,11,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/J.OMTM.2018.11.004","article-title":"Scalable production of AAV vectors in orbitally shaken HEK293 cells","volume":"13","author":"Blessing","year":"2019","journal-title":"Mol. Ther. - Methods & Clin. Dev."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.18609\/cgti.2019.175","article-title":"Cost modelling comparison of adherent multi-trays with suspension and fixed-bed bioreactors for the manufacturing of gene therapy products","volume":"5","author":"Cameau","year":"2019","journal-title":"Cell. Gene Ther. Insights"},{"key":"B3","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/S13568-019-0880-8","article-title":"Development of a simple and high-yielding fed-batch process for the production of porcine circovirus type 2 virus-like particle subunit vaccine","volume":"9","author":"Cao","year":"2019","journal-title":"Amb. Express"},{"key":"B4","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/J.JVIROMET.2013.10.038","article-title":"Production of adeno-associated virus (AAV) serotypes by transient transfection of HEK293 cell suspension cultures for gene delivery","volume":"196","author":"Chahal","year":"2014","journal-title":"J. Virological Methods"},{"key":"B5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0166-0934(02)00084-8","article-title":"Production of the baculovirus-expressed dengue virus glycoprotein NS1 can be improved dramatically with optimised regimes for fed-batch cultures and the addition of the insect moulting hormone, 20-Hydroxyecdysone","volume":"105","author":"Chan","year":"2002","journal-title":"J. Virol. Methods"},{"key":"B6","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/J.COCHE.2018.10.006","article-title":"Upstream process intensification and continuous manufacturing","volume":"22","author":"Chen","year":"2018","journal-title":"Curr. Opin. Chem. Eng."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1016\/j.ymthe.2019.11.002","article-title":"Efficient nuclease-free HR by clade F AAV requires high MOIs with high quality vectors","volume":"27","author":"Cook","year":"2020","journal-title":"Mol. Ther."},{"key":"B8","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1089\/GEN.41.S2.07","article-title":"efficient production of rAAV in a perfusion bioreactor using an ELEVECTA\u00ae stable producer cell line","volume":"41","author":"Coronel","year":"2021","journal-title":"Genet. Eng. Biotechnol. News"},{"key":"B9","doi-asserted-by":"publisher","first-page":"R102","DOI":"10.1093\/HMG\/DDZ128","article-title":"AAV-based gene therapies for the muscular dystrophies","volume":"28","author":"Crudele","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"B10","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/J.COPBIO.2021.12.009","article-title":"Leveraging rAAV bioprocess understanding and next generation bioanalytics development","volume":"74","author":"Escandell","year":"2022","journal-title":"Curr. Opin. Biotechnol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1002\/BIT.27766","article-title":"Integrating high cell density cultures with adapted laboratory evolution for improved Gag-HA virus-like particles production in stable insect cell lines","volume":"118","author":"Fernandes","year":"2021","journal-title":"Biotechnol. Bioeng."},{"key":"B12","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/J.JBIOTEC.2011.11.007","article-title":"Optimization of HEK-293S cell cultures for the production of adenoviral vectors in bioreactors using on-line OUR measurements","volume":"157","author":"G\u00e1lvez","year":"2012","journal-title":"J. Biotechnol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"830421","DOI":"10.3389\/FCENG.2022.830421","article-title":"Process improvement of adeno-associated virus (AAV) production","author":"Guan","year":"2022","journal-title":"Front. Chem. Eng."},{"key":"B14","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1002\/JCTB.5165","article-title":"ATF for cell culture harvest clarification: Mechanistic modelling and comparison with TFF","volume":"92","author":"Hadpe","year":"2017","journal-title":"J. Chem. Technol. Biotechnol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1080\/10826068.2018.1446151","article-title":"Integrated continuous biomanufacturing platform with ATF perfusion and one column chromatography operation for optimum resin utilization and productivity","volume":"48","author":"Kamga","year":"2018","journal-title":"Prep. Biochem. Biotechnol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/J.BEJ.2016.02.003","article-title":"Characterization and comparison of ATF and TFF in stirred bioreactors for continuous mammalian cell culture processes","volume":"110","author":"Karst","year":"2016","journal-title":"Biochem. Eng. J."},{"key":"B17","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/J.JBIOTEC.2009.01.021","article-title":"Identification and expression analysis of miRNAs during batch culture of HEK-293 cells","volume":"140","author":"Koh","year":"2009","journal-title":"J. Biotechnol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1001\/JAMAOPHTHALMOL.2013.7630","article-title":"Safety and effects of the vector for the leber hereditary optic neuropathy gene therapy clinical trial","volume":"132","author":"Koilkonda","year":"2014","journal-title":"JAMA Ophthalmol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"P52","DOI":"10.1186\/1753-6561-7-S6-P52","article-title":"Preliminary studies of cell culture strategies for bioprocess development based on HEK293 cells","volume":"7","author":"Liste-Calleja","year":"2013","journal-title":"BMC Proc."},{"key":"B20","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/BS.MIE.2021.08.003","article-title":"Exploring the design space of AAV transient-transfection in suspension cell lines","volume":"660","author":"Meade","year":"2021","journal-title":"Methods Enzymol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/J.VACCINE.2009.10.048","article-title":"Development of a simple and high-yielding fed-batch process for the production of influenza vaccines","volume":"28","author":"Meghrous","year":"2009","journal-title":"Vaccine"},{"key":"B22","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/J.YMTHE.2020.12.007","article-title":"Current clinical applications of in vivo gene therapy with AAVs","volume":"29","author":"Mendell","year":"2021","journal-title":"Mol. Ther."},{"key":"B23","doi-asserted-by":"publisher","first-page":"521","DOI":"10.18609\/cgti.2016.067","article-title":"AAV vector production: State of the art developments and remaining challenges","volume":"2","author":"Merten","year":"2016","journal-title":"Cell. Gene Ther. Insights"},{"key":"B24","doi-asserted-by":"publisher","first-page":"183","DOI":"10.4155\/pbp.14.16","article-title":"Manufacturing of viral vectors for gene therapy: Part I. Upstream processing","volume":"2","author":"Merten","year":"2014","journal-title":"Pharm. Bioprocess."},{"key":"B25","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3390\/PR8040487","article-title":"Holographic imaging of insect cell cultures: Online non-invasive monitoring of adeno-associated virus production and cell concentration","volume":"8","author":"Pais","year":"2020","journal-title":"Processes"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.18609\/cgti.2019.137","article-title":"Optimizing the clarification of industrial scale viral vector culture for gene therapy","volume":"5","author":"Raghavan","year":"2019","journal-title":"Cell. Gene Ther. Insights"},{"key":"B27","doi-asserted-by":"publisher","first-page":"815","DOI":"10.18609\/cgti.2018.083","article-title":"Overcoming bottlenecks in AAV manufacturing for gene therapy","volume":"4","author":"Smith","year":"2018","journal-title":"Cell. Gene Ther. Insights"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1002\/BTPR.2158","article-title":"Production of oncolytic adenovirus and human mesenchymal stem cells in a single-use, Vertical-Wheel bioreactor system: Impact of bioreactor design on performance of microcarrier-based cell culture processes","volume":"31","author":"Sousa","year":"2015","journal-title":"Biotechnol. Prog."},{"key":"B29","doi-asserted-by":"publisher","first-page":"3124","DOI":"10.1016\/J.VACCINE.2017.10.112","article-title":"High-cell-density cultivations to increase MVA virus production","volume":"36","author":"V\u00e1zquez-Ram\u00edrez","year":"2018","journal-title":"Vaccine"},{"key":"B30","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/J.JBIOTEC.2017.01.020","article-title":"Shear contributions to cell culture performance and product recovery in ATF and TFF perfusion systems","volume":"246","author":"Wang","year":"2017","journal-title":"J. Biotechnol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18609\/cgti.2021.010","article-title":"Optimization of AAV process development: Transfection matters","volume":"7","author":"Wosnitzka","year":"2021","journal-title":"Cell. Gene Ther. Insights"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1770669","DOI":"10.1080\/19420862.2020.1770669","article-title":"Biomanufacturing evolution from conventional to intensified processes for productivity improvement: A case study","volume":"12","author":"Xu","year":"2020","journal-title":"MAbs"},{"key":"B33","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/BTPR.1884","article-title":"Perfusion seed cultures improve biopharmaceutical fed-batch production capacity and product quality","volume":"30","author":"Yang","year":"2014","journal-title":"Biotechnol. Prog."},{"key":"B34","doi-asserted-by":"publisher","first-page":"101653","DOI":"10.1016\/J.ISCI.2020.101653","article-title":"Low shear stress increases recombinant protein production and high shear stress increases apoptosis in human cells","volume":"23","author":"Zhan","year":"2020","journal-title":"iScience"}],"container-title":["Frontiers in Bioengineering and Biotechnology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbioe.2022.1020174\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T05:06:07Z","timestamp":1667797567000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbioe.2022.1020174\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,7]]},"references-count":34,"alternative-id":["10.3389\/fbioe.2022.1020174"],"URL":"https:\/\/doi.org\/10.3389\/fbioe.2022.1020174","relation":{},"ISSN":["2296-4185"],"issn-type":[{"value":"2296-4185","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,7]]},"article-number":"1020174"}}